• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

造血细胞移植后肝脏 SOS/VOD 的改良诊断标准、分级分类和新阐明的病理生理学。

Modified diagnostic criteria, grading classification and newly elucidated pathophysiology of hepatic SOS/VOD after haematopoietic cell transplantation.

机构信息

Departments of, Department of, Pediatrics, New York Medical College, Valhalla, NY, USA.

Department of, Medicine, New York Medical College, Valhalla, NY, USA.

出版信息

Br J Haematol. 2020 Sep;190(6):822-836. doi: 10.1111/bjh.16557. Epub 2020 Mar 4.

DOI:10.1111/bjh.16557
PMID:32133623
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7483983/
Abstract

Sinusoidal obstruction syndrome (SOS), previously known as hepatic veno-occlusive disease (VOD), remains a multi-organ system complication following haematopoietic cell transplantation (HCT). When SOS/VOD is accompanied by multi-organ dysfunction, overall mortality rates remain >80%. However, the definitions related to the diagnosis and grading of SOS/VOD after HCT are almost 25 years old and require new and contemporary modifications. Importantly, the pathophysiology of SOS/VOD, including the contribution of dysregulated inflammatory and coagulation cascades as well as the critical importance of liver and vascular derived endothelial dysfunction, have been elucidated. Here we summarise new information on pathogenesis of SOS/VOD; identify modifiable and unmodifiable risk factors for disease development; propose novel, contemporary and panel opinion-based diagnostic criteria and an innovative organ-based method of SOS/VOD grading classification; and review current approaches for prophylaxis and treatment of SOS/VOD. This review will hopefully illuminate pathways responsible for drug-induced liver injury and manifestations of disease, sharpen awareness of risk for disease development and enhance the timely and correct diagnosis of SOS/VOD post-HCT.

摘要

窦状隙阻塞综合征(SOS),以前称为肝静脉阻塞病(VOD),在造血细胞移植(HCT)后仍然是多器官系统并发症。当 SOS/VOD 伴有多器官功能障碍时,总死亡率仍>80%。然而,与 HCT 后 SOS/VOD 诊断和分级相关的定义几乎已有 25 年的历史,需要进行新的和现代的修改。重要的是,SOS/VOD 的发病机制,包括失调的炎症和凝血级联反应的贡献以及肝和血管来源的内皮功能障碍的关键重要性,已经阐明。在这里,我们总结了关于 SOS/VOD 发病机制的新信息;确定了疾病发展的可改变和不可改变的危险因素;提出了新的、现代的、基于小组意见的诊断标准以及一种创新的基于器官的 SOS/VOD 分级分类方法;并回顾了目前预防和治疗 SOS/VOD 的方法。本综述有望阐明药物性肝损伤的发病途径和疾病表现,提高对疾病发展风险的认识,并提高 HCT 后 SOS/VOD 的及时和正确诊断。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/451a/7483983/21fbe6e8db75/nihms-1587492-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/451a/7483983/e9ee53de150c/nihms-1587492-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/451a/7483983/f46738ec3487/nihms-1587492-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/451a/7483983/21fbe6e8db75/nihms-1587492-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/451a/7483983/e9ee53de150c/nihms-1587492-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/451a/7483983/f46738ec3487/nihms-1587492-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/451a/7483983/21fbe6e8db75/nihms-1587492-f0003.jpg

相似文献

1
Modified diagnostic criteria, grading classification and newly elucidated pathophysiology of hepatic SOS/VOD after haematopoietic cell transplantation.造血细胞移植后肝脏 SOS/VOD 的改良诊断标准、分级分类和新阐明的病理生理学。
Br J Haematol. 2020 Sep;190(6):822-836. doi: 10.1111/bjh.16557. Epub 2020 Mar 4.
2
BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation.BCSH/BSBMT 指南:造血干细胞移植后静脉闭塞病(窦状隙阻塞综合征)的诊断和治疗。
Br J Haematol. 2013 Nov;163(4):444-57. doi: 10.1111/bjh.12558. Epub 2013 Sep 17.
3
Molecular Advances in Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease.窦房阻塞综合征/静脉阻塞性疾病的分子进展。
Int J Mol Sci. 2023 Mar 15;24(6):5620. doi: 10.3390/ijms24065620.
4
Risk Factors for Development of and Progression of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome.肝静脉闭塞病/窦状隙阻塞综合征发展和进展的风险因素。
Biol Blood Marrow Transplant. 2019 Jul;25(7):1271-1280. doi: 10.1016/j.bbmt.2019.02.018. Epub 2019 Feb 22.
5
[Diagnosis and treatment of sinusoidal obstruction syndrome (veno-occlusive disease)].窦性阻塞综合征(静脉闭塞性疾病)的诊断与治疗
Rinsho Ketsueki. 2021;62(8):1256-1264. doi: 10.11406/rinketsu.62.1256.
6
Earlier defibrotide initiation post-diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome improves Day +100 survival following haematopoietic stem cell transplantation.造血干细胞移植后,在静脉闭塞性疾病/窦性阻塞综合征诊断后更早开始使用去纤苷可提高第100天的生存率。
Br J Haematol. 2017 Jul;178(1):112-118. doi: 10.1111/bjh.14727. Epub 2017 Apr 26.
7
Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation.儿童患者窦状隙阻塞综合征/静脉阻塞性疾病的诊断和严重程度标准:来自欧洲血液和骨髓移植学会的新分类。
Bone Marrow Transplant. 2018 Feb;53(2):138-145. doi: 10.1038/bmt.2017.161. Epub 2017 Jul 31.
8
Evaluation of Circulating Endothelial Cells as Direct Marker of Endothelial Damage in Allo-Transplant Recipients at High Risk of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome.评估循环内皮细胞作为肝静脉闭塞病/窦性阻塞综合征高风险同种异体移植受者内皮损伤直接标志物的研究。
Transplant Cell Ther. 2024 Jun;30(6):580.e1-580.e14. doi: 10.1016/j.jtct.2024.03.026. Epub 2024 Apr 4.
9
Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a refined classification from the European society for blood and marrow transplantation (EBMT).成年患者肝窦阻塞综合征/静脉闭塞性疾病的诊断和严重程度标准:欧洲血液与骨髓移植学会(EBMT)的细化分类
Bone Marrow Transplant. 2023 Jul;58(7):749-754. doi: 10.1038/s41409-023-01992-8. Epub 2023 Apr 24.
10
Incidence of Anicteric Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome and Outcomes with Defibrotide following Hematopoietic Cell Transplantation in Adult and Pediatric Patients.成年和儿科患者造血细胞移植后非黄疸性静脉闭塞病/窦状隙阻塞综合征的发生率和去纤维蛋白治疗的结果。
Biol Blood Marrow Transplant. 2020 Jul;26(7):1342-1349. doi: 10.1016/j.bbmt.2020.03.011. Epub 2020 Mar 19.

引用本文的文献

1
First Report of Hematopoietic Stem Cell Transplantation for Children Diagnosed with Wiskott-Aldrich Syndrome in Vietnam.越南首例针对诊断为威斯科特-奥尔德里奇综合征儿童的造血干细胞移植报告。
J Blood Med. 2025 Aug 12;16:373-383. doi: 10.2147/JBM.S528827. eCollection 2025.
2
Clinical value of metagenomic next-generation sequencing in screening oropharyngeal colonization in patients undergoing allogeneic hematopoietic stem cell transplantation: a prospective observational study.宏基因组下一代测序在异基因造血干细胞移植患者口咽定植筛查中的临床价值:一项前瞻性观察研究。
Microbiol Spectr. 2025 Jul;13(7):e0002825. doi: 10.1128/spectrum.00028-25. Epub 2025 May 27.
3

本文引用的文献

1
Risk Factors for Development of and Progression of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome.肝静脉闭塞病/窦状隙阻塞综合征发展和进展的风险因素。
Biol Blood Marrow Transplant. 2019 Jul;25(7):1271-1280. doi: 10.1016/j.bbmt.2019.02.018. Epub 2019 Feb 22.
2
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells.ASTCT 细胞因子释放综合征和免疫效应细胞相关神经系统毒性的共识分级标准。
Biol Blood Marrow Transplant. 2019 Apr;25(4):625-638. doi: 10.1016/j.bbmt.2018.12.758. Epub 2018 Dec 25.
3
Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease after Autologous or Allogeneic Hematopoietic Stem Cell Transplantation in Children: a retrospective study of the Italian Hematology-Oncology Association-Hematopoietic Stem Cell Transplantation Group.
Ultrasonographic scoring system for SOS/VOD in pediatric hematopoietic stem cell transplant recipients.
儿童造血干细胞移植受者中SOS/VOD的超声评分系统
Int J Hematol. 2025 Apr 26. doi: 10.1007/s12185-025-03995-1.
4
Management of liver sinusoidal obstruction syndrome/veno-occlusive disease in adults: a 2025 perspective from an international expert group.成人肝窦阻塞综合征/肝小静脉闭塞病的管理:国际专家组的2025年展望
Bone Marrow Transplant. 2025 Apr 22. doi: 10.1038/s41409-025-02598-y.
5
Diagnostic accuracy of liver stiffness measurement for the diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome after hematopoietic stem cell transplantation (HSCT), the ELASTOVOD STUDY: an investigator-initiated, prospective, multicentre diagnostic clinical trial.ELASTOVOD研究:造血干细胞移植(HSCT)后肝硬度测量对诊断肝静脉闭塞病/窦性阻塞综合征的诊断准确性,一项研究者发起的前瞻性多中心诊断性临床试验。
Bone Marrow Transplant. 2025 Apr 19. doi: 10.1038/s41409-025-02570-w.
6
Oxaliplatin-induced portal hypertension manifesting as portosystemic shunt: A case report and review of sinusoidal obstruction syndrome in gastric cancer.奥沙利铂诱导的门静脉高压表现为门体分流:一例病例报告及胃癌中窦性阻塞综合征的综述
DEN Open. 2025 Mar 29;5(1):e70109. doi: 10.1002/deo2.70109. eCollection 2025 Apr.
7
Operational procedure sharing pathway in veno-occlusive disease: a Delphi consensus-based recommendations.静脉闭塞性疾病的操作程序共享路径:基于德尔菲共识的建议
Front Oncol. 2025 Mar 12;15:1498782. doi: 10.3389/fonc.2025.1498782. eCollection 2025.
8
Defibrotide for the Treatment of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome in Paediatric Patients Who Did Not Receive Haematopoietic Stem Cell Transplantation: Case Reports of Patients From a German Academic Hospital.去纤苷治疗未接受造血干细胞移植的儿科患者的静脉闭塞性疾病/窦性阻塞综合征:来自德国一家学术医院患者的病例报告
EJHaem. 2025 Jan 23;6(1):e1094. doi: 10.1002/jha2.1094. eCollection 2025 Feb.
9
A case of late-onset sinusoidal obstruction syndrome diagnosed histologically before meeting diagnostic criteria.一例在达到诊断标准之前经组织学诊断的迟发性肝窦阻塞综合征病例。
Int J Hematol. 2025 Mar;121(3):421-426. doi: 10.1007/s12185-024-03909-7. Epub 2025 Jan 5.
10
Continuous Kidney Replacement Therapy in Children With Sinusoidal Obstruction Syndrome After Hematopoietic Cell Transplant: Outcome and Liberation.造血细胞移植后窦性阻塞综合征患儿的连续性肾脏替代治疗:结局与撤机
Pediatr Blood Cancer. 2025 Mar;72(3):e31473. doi: 10.1002/pbc.31473. Epub 2024 Dec 9.
儿童自体或异基因造血干细胞移植后窦状隙阻塞综合征/静脉闭塞性疾病:意大利血液学-肿瘤学会-造血干细胞移植组的回顾性研究。
Biol Blood Marrow Transplant. 2019 Feb;25(2):313-320. doi: 10.1016/j.bbmt.2018.09.027. Epub 2018 Sep 26.
4
Liver Complications Following Treatment of Hematologic Malignancy With Anti-CD22-Calicheamicin (Inotuzumab Ozogamicin).抗 CD22-加利车霉素(奥滨尤妥珠单抗)治疗血液系统恶性肿瘤后的肝脏并发症。
Hepatology. 2019 Feb;69(2):831-844. doi: 10.1002/hep.30222. Epub 2019 Jan 18.
5
Early Clinical Predictors of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Myeloablative Stem Cell Transplantation.骨髓清除性干细胞移植后肝静脉闭塞病/窦状隙阻塞综合征的早期临床预测因子。
Biol Blood Marrow Transplant. 2019 Jan;25(1):137-144. doi: 10.1016/j.bbmt.2018.07.039. Epub 2018 Aug 3.
6
Risk Score for the Development of Veno-Occlusive Disease after Allogeneic Hematopoietic Cell Transplant.异基因造血细胞移植后静脉闭塞病的风险评分。
Biol Blood Marrow Transplant. 2018 Oct;24(10):2072-2080. doi: 10.1016/j.bbmt.2018.06.013. Epub 2018 Jun 19.
7
Novel Ultrasonographic Scoring System of Sinusoidal Obstruction Syndrome after Hematopoietic Stem Cell Transplantation.新型造血干细胞移植后肝窦阻塞综合征超声评分系统。
Biol Blood Marrow Transplant. 2018 Sep;24(9):1896-1900. doi: 10.1016/j.bbmt.2018.05.025. Epub 2018 May 24.
8
Clinical diagnosis of veno-occlusive disease using contrast enhanced ultrasound.使用超声造影增强技术对肝静脉闭塞病进行临床诊断。
Bone Marrow Transplant. 2018 Oct;53(10):1369-1371. doi: 10.1038/s41409-018-0198-1. Epub 2018 May 22.
9
Final results from a defibrotide treatment-IND study for patients with hepatic veno-occlusive disease/sinusoidal obstruction syndrome.一项关于去纤维肽治疗肝静脉闭塞病/窦状隙阻塞综合征患者的 IND 研究的最终结果。
Br J Haematol. 2018 Jun;181(6):816-827. doi: 10.1111/bjh.15267. Epub 2018 May 16.
10
Using liver elastography to diagnose sinusoidal obstruction syndrome in pediatric patients undergoing hematopoetic stem cell transplant.利用肝脏弹性成像技术诊断接受造血干细胞移植的儿科患者的窦性阻塞综合征。
Bone Marrow Transplant. 2020 Mar;55(3):523-530. doi: 10.1038/s41409-017-0064-6. Epub 2018 Jan 15.